Comment on "pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance

Free Radical Biology and Medicine

Volumn 50, Issue 12, 2011, Pages 1726-1727

  Cullen, Joseph J ^a,b   Spitz, Douglas R ^c   Buettner, Garry R ^c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; GEMCITABINE;

CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DRUG MEGADOSE; DRUG POTENTIATION; HUMAN; INTRAOPERATIVE RADIOTHERAPY; NOTE; PANCREAS CANCER; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASCORBIC ACID; DEOXYCYTIDINE; DRUG SYNERGISM; HUMANS; INJECTIONS, INTRAVENOUS; MICE; PANCREATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 79956116640     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.03.030     Document Type: Note

References (30)

1. M.G. Espey, P. Chen, B. Chalmers, J. Drisko, A.Y. Sun, M. Levine, and Q. Chen Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer Free Radic. Biol. Med. 51 2011 xxx-yyy
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J. Clin. 60 2010 277 300
3. S.R. Bramhall, W.H. Allum, A.G. Jones, A. Allwood, C. Cummins, and J.P. Neoptolemos Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the epidemiological study Br. J. Surg. 82 1995 111 115
4. C.J. Yeo, and J.L. Cameron Pancreatic cancer Curr. Probl. Surg. 36 1999 59 152
5. R. White, C. Lee, and M. Anscher Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas Ann. Surg. Oncol. 6 1999 38 45 (Pubitemid 29077487)
6. W.J. McCormick Cancer: the preconditioning factor in pathogenesis Arch. Pediatr. 71 1954 313 322
7. W.J. McCormick Cancer: a collagen disease, secondary to a nutritional deficiency? Arch. Pediatr. 76 1959 166 171
8. E. Cameron, and D. Rotman Ascorbic acid, cell proliferation, and cancer Lancet 299 1972 542
9. E. Cameron, and L. Pauling Ascorbic acid and the glycosaminoglycans: an orthomolecular approach to cancer and other diseases Oncology 27 1973 181 192
10. E. Cameron, and L. Pauling Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer Proc. Natl. Acad. Sci. U. S. A. 73 1976 3685 3689
11. E. Cameron, and A. Campbell The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer Chem. Biol. Interact. 9 1974 285 315
12. E. Cameron, and L. Pauling Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer Proc. Natl. Acad. Sci. U. S. A. 75 1978 4538 4542 (Pubitemid 9028392)
13. E. Cameron, and A. Campbell Innovation vs. quality control: an 'unpublishable' clinical trial of supplemental ascorbate in incurable cancer Med. Hypotheses 36 1991 185 189
14. A. Murata, F. Morishige, and H. Yamaguchi Prolongation of survival times of terminal cancer patient by administration of large doses of ascorbate Int. J. Vitam. Nutr. Res. Suppl. 23 1982 103 113
15. A. Campbell, T. Jack, and E. Cameron Reticulum cell sarcoma: two complete 'spontaneous' regressions, in response to high dose ascorbic acid therapy. A report on subsequent progress Oncology 48 1991 495 497
16. E.T. Creagan, C.G. Moertel, J.R. O'Fallon, A.J. Schutt, M.J. O'Connell, J. Rubin, and S. Frytak Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: a controlled trial N. Engl. J. Med. 301 1979 687 690 (Pubitemid 10240445)
17. C.G. Moertel, T.R. Flemin, E.T. Creagan, J. Rubin, M.J. O'Connell, and M.M. Ames High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy: a randomized double-blind comparison N. Engl. J. Med. 312 1985 137 141 (Pubitemid 15192859)
18. M. Levine, C. Conry-Cantilena, Y. Wang, R.W. Welch, P.W. Washko, K.R. Dhariwal, J.B. Park, A. Lazarev, J.F. Graumlich, J. King, and L.R. Cantilena Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance Proc. Natl. Acad. Sci. U. S. A. 93 1996 3704 3709 (Pubitemid 26125678)
19. S.J. Padayatty, and M. Levine Reevaluation of vitamin C in cancer treatment: emerging evidence, open minds and serendipity J. Am. Coll. Nutr. 19 2000 423 425 (Pubitemid 30629145)
20. M. Levine, S.J. Padayatty, and M.G. Espey Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries Adv. Nutr. 2 2011 78 88
21. J.F. Graumlich, T.M. Ludden, C. Conry-Cantilena, L.R. Cantilena Jr., Y. Wang, and M. Levine Pharmacokinetic model for ascorbic acid in healthy male volunteers during depletion and repletion Pharm. Res. 14 1997 1133 1139 (Pubitemid 27432533)
22. F.R. Klenner Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology J. Appl. Nutr. 23 1971 61 87
23. N.H. Riordan, H.D. Riordan, X. Meng, Y. Li, and J.A. Jackson Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent Med. Hypotheses 44 1995 207 213
24. L.J. Hoffer, M. Levine, S. Assouline, D. Melnychuk, S.J. Padayatty, K. Rosadiuk, C. Rousseau, L. Robitaille, and W.H. Miller Jr. Phase I clinical trial of i.v. ascorbic acid in advanced malignancy Ann. Oncol. 19 2008 1969 1974
25. S.J. Padayatty, A.Y. Sun, Q. Chen, M.G. Espey, J. Drisko, and M. Levine Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects PLoS One 5 2010 e11414
26. Q. Chen, M.G. Espey, M.C. Krishna, J.B. Mitchell, C.P. Corpe, G.R. Buettner, E. Shacter, and M. Levine Ascorbic acid at pharmacologic concentrations selectively kills cancer cells: ascorbic acid as a pro-drug for hydrogen peroxide delivery to tissues Proc. Natl. Acad. Sci. U. S. A. 102 2005 13604 13609 (Pubitemid 41420895)
27. J. Du, S. Martin, M. Levine, B. Wagner, G.R. Buettner, S.H. Wang, A.F. Tagheyev, C. Du, C.M. Knudson, and J.J. Cullen Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer Clin. Can. Res. 16 2010 509 520
28. F.Q. Schafer, and G.R. Buettner Redox state of the cell as viewed though the glutathione disulfide/glutathione couple Free Radic. Biol. Med. 30 2001 1191 1212 (Pubitemid 32463931)
29. Y. Song, and G.R. Buettner Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide Free Radic. Biol. Med. 49 2010 919 962
30. http://www.cancer.gov/ncicancerbulletin/110309/page1 accessed on 22 March 2011